N-α-acetyltransferase 10 protein is a negative regulator of 28S proteasome through interaction with PA28β

FEBS Letters

Volumn 587, Issue 11, 2013, Pages 1630-1637

  Min, Li ^a   Xu, Huiyu ^a   Wang, Juan ^b   Qu, Like ^a   Jiang, Beihai ^a   Zeng, Yan ^a   Meng, Lin ^a   Jin, Hongwei ^b   Shou, Chengchao ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Naa10p; PA28 ; Proteasome activity

Indexed keywords

ACYLTRANSFERASE; BINDING PROTEIN; CHYMOTRYPSIN; ENZYME ACTIVATOR; N ALPHA ACETYLTRANSFERASE 10 PROTEIN; PEPTIDE ALPHA N ACETYLTRANSFERASE A; PROTEASOME ACTIVATOR 28 BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL FREE SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ACETYLATION; AMINO ACID SEQUENCE; CELL LINE, TUMOR; CHYMOTRYPSIN; HUMANS; KINETICS; N-TERMINAL ACETYLTRANSFERASE A; N-TERMINAL ACETYLTRANSFERASE E; PEPTIDE LIBRARY; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS;

EID: 84878245198     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.04.016     Document Type: Article

References (36)

1. T. Arnesen, D. Anderson, C. Baldersheim, M. Lanotte, J.E. Varhaug, and J.R. Lillehaug Identification of the hARD1-NATH Biochem. J. 386 2005 433 443
2. P. Van Damme, T. Arnesen, and K. Gevaert Protein alpha-N-acetylation studied by N-terminomics FEBS J. 278 20 2011 3822 3834
3. T. Arnesen, P. Van Damme, B. Polevoda, K. Helsens, R. Evjenth, N. Colaert, J.E. Varhaug, J. Vandekerckhove, J.R. Lillehaug, and F. Sherman Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans Proc. Natl. Acad. Sci. USA 106 20 2009 8157 8162
4. K.K. Starheim, K. Gevaert, and T. Arnesen Protein N-terminal acetyltransferases: when the start matters Trends Biochem. Sci. 37 4 2012 152 161
5. J.H. Lim, J.W. Park, and Y.S. Chun Human arrest defective 1 acetylates and activates β-catenin, promoting lung cancer cell proliferation Cancer Res. 66 22 2006 10677 10682
6. J.H. Seo, J.H. Cha, J.H. Park, C.H. Jeong, Z.Y. Park, H.S. Lee, S.H. Oh, J.H. Kang, S.W. Suh, and K.H. Kim Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation Cancer Res. 70 11 2010 4422 4432
7. F.C. Lee, D.S.C. Ou, S.B. Lee, L.H. Chang, R.K. Lin, Y.S. Li, K.U. Anup, X. Cheng, Y.C. Wang, H.S. Hsu, M. Hsiao, C.W. Wu, and L.J. Juan HNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing J. Clin. Invest. 120 2010 2920 2930
8. H. Xu, B. Jiang, L. Meng, T. Ren, Y. Zeng, J. Wu, L. Qu, and C. Shou N-α-acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression Carcinogenesis 33 6 2012 1193 1203
9. T. Arnesen, D. Gromyko, F. Pendino, A. Ryningen, J.E. Varhaug, and J.R. Lillehaug Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-α-acetyltransferase complex Oncogene 25 31 2006 4350 4360
10. K.T. Hua, C.T. Tan, G. Johansson, J.M. Lee, P.W. Yang, H.Y. Lu, C.K. Chen, J.L. Su, P.B. Chen, and Y.L. Wu N-α-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity Cancer Cell 19 2 2011 218 231
11. H.P. Kuo, D.F. Lee, C.T. Chen, M. Liu, C.K. Chou, H.J. Lee, Y. Du, X. Xie, Y. Wei, and W. Xia ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway Sci. Signal. 3 108 2010 ra9
12. J.H. Lim, Y.S. Chun, and J.W. Park Hypoxia-inducible factor 1 alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin Cancer Res. 68 13 2008 5177 5184
13. N. Ohkawa, S. Sugisaki, E. Tokunaga, K. Fujitani, T. Hayasaka, M. Setou, and K. Inokuchi N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development Genes Cells 13 11 2008 1171 1183
14. N. Ohkawa, S. Sugisaki, E. Tokunaga, K. Fujitani, M. Setou, and K. Inokuchi ARD1-NAT1 complex regulates neuronal dendritic arborization through α-tubulin acetylation Neurosci. Res. 58 2007 S88
15. T. Ren, B. Jiang, G. Jin, J. Li, B. Dong, J. Zhang, L. Meng, J. Wu, and C. Shou Generation of novel monoclonal antibodies and their application for detecting ARD1 expression in colorectal cancer Cancer Lett. 264 1 2008 83 92
16. B. Jiang, T. Ren, B. Dong, L. Qu, G. Jin, J. Li, H. Qu, L. Meng, C. Liu, and J. Wu Peptide mimic isolated by autoantibody reveals human arrest defective 1 overexpression is associated with poor prognosis for colon cancer patients Am. J. Pathol. 177 3 2010 1095 1103
17. C.H. Yi, H. Pan, J. Seebacher, I.H. Jang, S.G. Hyberts, G.J. Heffron, H. Vander, G. Matthew, R. Yang, F. Li, and J.W. Locasale Metabolic regulation of protein N-alpha-acetylation by Bcl-xL promotes cell survival Cell 146 4 2011 607 620
18. T.V. Kalvik, and T. Arnesen Protein N-terminal acetyltransferases in cancer Oncogene 32 3 2013 269 276
19. B.M. Stadtmueller, and C.P. Hill Proteasome activators Mol. Cell 41 1 2011 8 19
20. P. Deriziotis, R. André, D.M. Smith, R. Goold, K.J. Kinghorn, M. Kristiansen, J.A. Nathan, R. Rosenzweig, D. Krutauz, and M.H. Glickman Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry EMBO J. 30 15 2011 3065 3077
21. P. Friedl, and K. Wolf Tube travel: the role of proteases in individual and collective cancer cell invasion Cancer Res. 68 18 2008 7247 7249
22. C.S. Arendt, and M. Hochstrasser Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly EMBO J. 18 13 1999 3575 3585
23. V. Spataro, C. Norbury, and A.L. Harris The ubiquitin-proteasome pathway in cancer Br. J. Cancer 77 3 1998 448 455
24. F. Brégégère, Y. Milner, and B. Friguet The ubiquitin-proteasome system at the crossroads of stress-response and ageing pathways: a handle for skin care? Ageing Res. Rev. 5 1 2006 60 90
25. J. Li, S.R. Powell, and X. Wang Enhancement of proteasome function by PA28α overexpression protects against oxidative stress FASEB J. 25 3 2010 883 893
26. K. Kanai, S. Aramata, S. Katakami, K. Yasuda, and K. Kataoka Proteasome activator PA28γ stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA J. Mol. Endocrinol. 47 1 2011 119 127
27. N. de Graaf, M.J.G. van Helden, K. Textoris-Taube, T. Chiba, D.J. Topham, P.M. Kloetzel, D.M.W. Zaiss, and A.J.A.M. Sijts PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo Eur. J. Immunol. 41 4 2011 926 935
28. A. Sali, L. Potterton, F. Yuan, H. van Vlijmen, and M. Karplus Evaluation of comparative protein modeling by MODELLER Proteins 23 3 1995 318 326
29. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus CHARMM: a program for macromolecular energy, minimization, and dynamics calculations J. Comp. Chem. 4 2 1983 187 217
30. K.P.B. Wiehe, J. Mintseris, W.W. Tong, R. Anderson, R. Chen, and Z. Weng ZDOCK and RDOCK performance in CAPRI rounds 3, 4, and 5 Proteins 60 2 2005 207 213
31. J. Li, and M. Rechsteiner Molecular dissection of the 11S REG (PA28) proteasome activators Biochimie 83 2001 373 383
32. A. Sijts, Y. Sun, K. Janek, S. Kral, A. Paschen, D. Schadendorf, and P.M. Kloetzel The role of the proteasome activator PA28 in MHC class I antigen processing Mol. Immunol. 39 2002 165 169
33. M. Yu, M. Ma, C. Huang, H. Yang, J. Lai, S. Yan, L. Li, M. Xiang, and D. Tan Correlation of expression of human arrest-defective-1 (hARD1) protein with breast cancer Cancer Invest. 27 10 2009 978 983
34. Q. Huang, Q. Huang, W. Lin, J. Lin, and X. Lin Potential roles for PA28β in gastric adenocarcinoma development and diagnosis J. Cancer Res. Clin. Oncol. 136 8 2010 1275 1282
35. D.L. Zheng, Q.L. Huang, F. Zhou, Q.J. Huang, J.Y. Lin, and X. Lin PA28β regulates cell invasion of gastric cancer via modulating the expression of chloride intracellular channel 1 J. Cell. Biochem. 113 2012 1537 1546
36. A. Arlt, I. Bauer, C. Schafmayer, J. Tepel, S.S. Müerköster, M. Brosch, C. Röder, H. Kalthoff, J. Hampe, and M.P. Moyer Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) Oncogene 28 45 2009 3983 3996